U.S. Electrical Stock News

NYSE:MIAX
NYSE:MIAXCapital Markets

Is It Too Late To Consider Miami International Holdings (MIAX) After Recent Share Price Gains?

If you are wondering whether Miami International Holdings at around US$49.77 is priced attractively or not, the key question is how that tag compares with what the business could reasonably be worth. Over shorter periods, the stock has been active, with returns of 7.1% over the last 7 days, 20.5% over the last 30 days and 14.0% year to date, which hints that expectations and perceived risk are shifting. Recent coverage has focused on Miami International Holdings as part of broader...
NYSE:SES
NYSE:SESElectrical

SES AI Shifts Toward Defense And Storage With New Contracts And AI

SES AI (NYSE:SES) has converted its South Korea facility to produce NDAA-compliant drone battery cells for defense customers. The company signed a multi-year, $20 million distribution agreement with ATG EPower for North American energy storage systems. SES AI is applying AI tools to optimize defense-focused battery products, expanding its use of the technology beyond R&D. SES AI, trading at about $0.921 per share, is shifting focus beyond long-cycle EV battery development toward products...
NYSE:GXO
NYSE:GXOLogistics

Is It Time To Reassess GXO Logistics (GXO) After Recent Share Price Pullback?

Wondering if GXO Logistics at around US$51.88 is offering you value right now, or if the recent price action has already reflected most of the upside? The stock has pulled back, with a 9.2% decline over the last week and a 2.6% decline over the last month, while the 1 year return sits at 30.6% and the 3 year return at a 4.9% decline. Recent coverage has focused on how GXO Logistics fits into broader logistics and supply chain themes, as investors reassess the sector after a strong 1 year...
NYSE:CPA
NYSE:CPAAirlines

Three Dividend Fortresses One Hub Risk One Retail Puzzle One Tanker Wildcard

Global markets are on edge, with inflation, interest rate expectations, energy prices, and geopolitics all competing for attention, yet many investors still want income that feels relatively steady. That is where high yield dividend fortresses come in: stocks offering 5%+ dividend yields and balance sheet strength that can help keep payouts at the center of your plan. Rather than chasing the hottest story, this screener focuses on resilience and cash returns. In this article, you will see...
NasdaqGS:SLDP
NasdaqGS:SLDPAuto Components

Solid Power (SLDP) Valuation Check As Electrolyte Commercialization And Partnerships Progress

Solid Power (SLDP) is in focus after reporting first quarter 2026 results alongside progress on its electrolyte commercialization plans, giving you fresh numbers and project updates to weigh against the current share price. See our latest analysis for Solid Power. Solid Power’s recent earnings update, electrolyte progress with SK On and Samsung SDI, and funding raise come after a volatile period, with a 1-day share price return of negative 12.71% and a 1-year total shareholder return of very...
NasdaqGS:NTSK
NasdaqGS:NTSKSoftware

Netskope Unveils AgentSkope As Investors Weigh AI Automation Prospects

Netskope (NasdaqGS:NTSK) has introduced AgentSkope, an AI-driven agentic operations platform for automating security and network workflows. The new platform brings a suite of AI-powered agents designed to handle routine and complex operational tasks for security and network teams. This launch adds a fresh product to Netskope's portfolio in automated cybersecurity operations, an area where many enterprises are seeking more efficiency. Netskope trades at $11.4, with the stock showing a 14.5%...
NasdaqCM:CORT
NasdaqCM:CORTPharmaceuticals

Corcept’s ALS Survival Signal Reframes Cortisol Modulation And Growth Outlook

Corcept Therapeutics reported long term survival data from its DAZALS Phase 2 trial of dazucorilant in ALS. Patients receiving 300 mg daily experienced an 87% reduction in risk of death at two years. The trial did not meet its primary functional endpoint, but the survival benefit attracted attention at the ENCALS 2025 meeting. For investors tracking NasdaqCM:CORT, this new ALS data adds another layer to the story around Corcept Therapeutics beyond its core cortisol modulation work. The...
NYSE:RBA
NYSE:RBACommercial Services

Is It Too Late To Reassess RB Global (RBA) After Its Recent Share Price Surge?

Investors may be wondering if RB Global at around US$103 a share is still offering value or if most of the upside is already priced in. The stock has been fairly steady year to date, with a 0.1% return. However, that headline number masks a 5.8% gain over the past month, a small 0.8% slip in the last week, and a return of 97.8% over three years and 85.2% over five years. Recent coverage has focused on RB Global's role in the Commercial Services sector and how investors are reacting to its...